Hikma Pharmaceuticals PLC

Pharmaceuticals

Company Summary

Hikma Pharmaceuticals PLC is a pharmaceutical company that develops, manufactures, and sells a variety of generic, branded, and in-licensed pharmaceuticals. Solid, semi-solid, liquid, and injectable final dosage forms are available from the company. Injectables, Generics, and Branded are the three segments through which it works. The company was created in 1978 and is headquartered in London, England.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

29.5
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E3.6S16.9G8.7

Refinitiv

Overall ESG Rating :

71
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E41S74G89

Overall ESG Rating :

BBB
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Hikma is average among 80 companies in the pharmaceuticals industry.

Temperature Rise :

1.7℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned